Does a female patient with a hemoglobin A1c (HbA1c) of 5.9% meet criteria for prediabetes?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 27, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Yes, an A1c of 5.9% meets the diagnostic criteria for prediabetes.

According to the most recent 2025 American Diabetes Association guidelines, prediabetes is defined as an A1c between 5.7-6.4% (39-47 mmol/mol), and your patient's A1c of 5.9% falls squarely within this range 1.

Diagnostic Criteria

The 2025 ADA Standards of Care clearly establish three ways to diagnose prediabetes 1:

  • Fasting plasma glucose: 100-125 mg/dL
  • 2-hour oral glucose tolerance test: 140-199 mg/dL
  • A1c: 5.7-6.4%

Your patient meets the A1c criterion definitively.

Risk Stratification Within Prediabetes

While she has prediabetes, it's important to recognize that her A1c of 5.9% places her in the "lower" prediabetes range (5.7-6.0%) rather than "higher" prediabetes (6.1-6.4%), which carries different risk profiles 2:

  • 10-year diabetes risk: Patients with A1c 5.7-6.0% have approximately 4-fold increased risk of developing diabetes compared to normal A1c
  • 10-year ASCVD risk: Modestly elevated (HR 1.08-1.18) compared to normal A1c
  • Those with A1c 6.1-6.4% face dramatically higher risks (14-15 fold for diabetes, HR 1.25-1.27 for ASCVD)

Clinical Implications and Management Priority

The diagnosis of prediabetes should trigger annual A1c monitoring 1. The 2025 guidelines explicitly state that people with prediabetes (A1c ≥5.7%) should be tested yearly.

Key Management Considerations:

Assess abdominal obesity status immediately. Research demonstrates that waist circumference significantly modifies diabetes risk even in lower-range prediabetes 2. Women with A1c 5.7-6.0% and increased waist circumference show meaningfully elevated progression to diabetes, making weight management a critical intervention target.

Prioritize lifestyle modification as first-line therapy, focusing on:

  • Weight reduction if overweight/obese
  • Physical activity
  • Dietary modification

Screen for additional cardiovascular risk factors including hypertension, dyslipidemia, and family history, as prediabetes confers increased ASCVD risk independent of glucose levels 2.

Important Caveats

The A1c criterion identifies different patients than glucose-based testing. Studies show only 55% concordance between A1c and glucose criteria for prediabetes 3. Patients diagnosed by A1c alone tend to be older, more likely female, and have different metabolic profiles than those identified by fasting glucose. This doesn't invalidate the diagnosis—it simply means A1c captures a distinct at-risk population.

Consider confirmatory testing with fasting glucose or OGTT if clinical suspicion differs from A1c result, particularly in populations where A1c may be less reliable (hemoglobinopathies, anemia, recent blood loss). However, the positive predictive value of A1c 5.7-6.4% for true dysglycemia is only 39% when confirmed by OGTT 4, so some patients may have normal glucose tolerance despite elevated A1c.

Ensure adequate carbohydrate intake (at least 150 g/day for 3 days) preceded the A1c test if you plan confirmatory glucose testing 1.

Related Questions

What is the plasma glucose threshold defining hypoglycemia in a nondiabetic patient?
What are the 2026 American Diabetes Association (ADA) guideline updates for the management of adults with type 2 diabetes?
For a 60-year-old, 90-kg female with type 2 diabetes receiving total parenteral nutrition containing 155 g dextrose and currently given 37 units regular insulin, with an insulin sensitivity factor of 20 and overnight blood glucose readings of 234 mg/dL and 223 mg/dL, what amount of regular insulin should be added to the TPN?
In an adult with hemoglobin A1c 6.0% and BMI 33 kg/m², should metformin be initiated if the A1c remains in the prediabetic range?
How should abdominal pain be evaluated and managed in a 42-year-old male with diabetes?
What do low‑attenuation lesions in the proximal pancreatic tail measuring 2.9 × 1.3 cm with associated atrophy of the distal pancreatic tail and dilatation of the pancreatic duct, together with a 1.7 cm low‑attenuation lesion in the right hepatic lobe on contrast‑enhanced abdominal CT indicate, and what is the likely prognosis?
What is the cause of a sigmoid septum seen on an echocardiogram?
In a generally healthy adult who drinks socially (one to two standard drinks occasionally), how long does it take for liver enzyme levels (ALT, AST, GGT) to return to baseline after the last drink?
In an elderly patient with chronic kidney disease stage 3b, what blood pressure target should be aimed for?
Can patients on dialysis take nonsteroidal anti-inflammatory drugs (NSAIDs)?
At what hemoglobin level should supplemental oxygen be initiated in a non‑cardiac patient?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.